Chemours
384 hedge funds and large institutions have $2.62B invested in Chemours in 2020 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 92 increasing their positions, 127 reducing their positions, and 60 closing their positions.
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
36% more capital invested
Capital invested by funds: $1.93B → $2.62B (+$690M)
0.12% less ownership
Funds ownership: 76.7% → 76.58% (-0.12%)
3% less funds holding
Funds holding: 396 → 384 (-12)
15% less first-time investments, than exits
New positions opened: 51 | Existing positions closed: 60
28% less repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 127
60% less call options, than puts
Call options by funds: $40.8M | Put options by funds: $103M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$21.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$20.3M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
+$15.8M |
| 4 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
+$13M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$12.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$30.1M |
| 2 |
SC
Sessa Capital
New York
|
-$20M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$17.2M |
| 4 |
SCM
Scopia Capital Management
New York
|
-$11.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$10.9M |
CC Hedge Fund Activity: Q3 2020 in Review
384 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q3 2020, worth a combined $2.62B — up 36% from $1.93B a quarter earlier.
Sellers outnumbered buyers: 60 funds closed out of CC and 51 opened new positions — a net loss of 9 holders — while 127 trimmed existing stakes and 92 added.
The largest buyer was Citadel Advisors, adding an estimated $21.5M. The largest seller was Invesco, cutting an estimated $30.1M.
- 384 institutional investors held Chemours (CC) as of Q3 2020, down from 396 in Q2 2020.
- Funds reported $2.62B of Chemours stock for Q3 2020, up 36% quarter-over-quarter.
- 51 funds opened new Chemours positions in Q3 2020 and 60 closed out, a net change of -9 holders.
- The largest Chemours buyer in Q3 2020 was Citadel Advisors, an estimated $21.5M added.
- The largest Chemours seller in Q3 2020 was Invesco, an estimated $30.1M sold.
Based on aggregated 13F filings for Q3 2020.